entospharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Enabling Tomorrow’s Nanomedicines | Entos |
| Description | Next-Generation Genetic Medicine Entos Pharmaceuticals develops next generation nucleic acid-based therapies using our proprietary Fusogenix drug delivery |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 75.2.70.75 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
entospharma.com Valuation
|
US$6,306,683
Last updated: 2023-05-02 18:58:00
entospharma.com has Semrush global rank of 1,678,268. entospharma.com has an estimated worth of US$ 6,306,683, based on its estimated Ads revenue. entospharma.com receives approximately 727,695 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, entospharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,306,683 |
| Daily Ads Revenue | US$5,822 |
| Monthly Ads Revenue | US$174,647 |
| Yearly Ads Revenue | US$2,095,760 |
| Daily Unique Visitors | 48,513 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| entospharma.com. | A | 600 | IP: 75.2.70.75 |
| entospharma.com. | A | 600 | IP: 99.83.190.102 |
| entospharma.com. | NS | 3600 | NS Record: ns71.domaincontrol.com. |
| entospharma.com. | NS | 3600 | NS Record: ns72.domaincontrol.com. |
| entospharma.com. | MX | 3600 | MX Record: 10 mx-01-us-east-2.prod.hydra.sophos.com. |
| entospharma.com. | MX | 3600 | MX Record: 20 mx-02-us-east-2.prod.hydra.sophos.com. |
| entospharma.com. | TXT | 1800 | TXT Record: sophos-domain-verification=5ae296c26338cba903a2b18325f7fb15d9e21e88 |
| entospharma.com. | TXT | 1800 | TXT Record: NETORGFT8135529.onmicrosoft.com |
| entospharma.com. | TXT | 1800 | TXT Record: google-site-verification=A4S55HRrFMvQqtyfEP8HTACIKwFDcqK3gBAjTrivbtk |
| entospharma.com. | TXT | 1800 | TXT Record: v=spf1 include:_spf.google.com include:_spf.prod.hydra.sophos.com ~all |
HtmlToTextCheckTime:2023-05-02 18:58:00
| FUSOGENIX PIPELINE ABOUT NEWS CONTACT Next-Generation Genetic Medicine Delivery A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. We develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of mRNA or DNA into target cells through direct fusion. Fusogenix PLVs use a novel mechanism of action to deliver nucleic acids, intact and unmodified, directly into target cells. The Fusogenix PLV technology is applicable to a wide range of genetic medicines. ABOUT OUR COVID-19 DNA VACCINE COVID-19 DNA Vaccine We are dedicated to developing a safe and effective DNA vaccine to protect against COVID-19 using our Fusogenix PLV platform. On April 15, 2021, the first recruits (healthy adults aged 18-84 years of age) were dosed to start the Phase 1 trial |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Mon, 25 Oct 2021 04:14:41 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://entospharma.com/ HTTP/2 301 server: openresty date: Mon, 25 Oct 2021 04:14:41 GMT content-type: text/html content-length: 166 location: https://www.entospharma.com/ HTTP/2 200 server: openresty date: Mon, 25 Oct 2021 04:14:41 GMT content-type: text/html content-length: 16403 accept-ranges: bytes via: 1.1 varnish age: 3219 x-served-by: cache-dca17745-DCA x-cache: HIT x-cache-hits: 1 x-timer: S1635135282.743002,VS0,VE1 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
entospharma.com Whois Information
Domain Name: ENTOSPHARMA.COM Registry Domain ID: 1650703410_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-14T18:44:58Z Creation Date: 2011-04-13T16:34:51Z Registry Expiry Date: 2026-04-13T16:34:51Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS71.DOMAINCONTROL.COM Name Server: NS72.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T08:55:12Z <<< |